Combined ovulation triggering with GnRH agonist and hCG in IVF patients

References

• Orvieto R. Triggering final follicular maturation–hCG, GnRH-agonist or both, when and to whom? J Ovarian Res 2015;8:60–7.
   PubMed Web of Science ®Google Scholar
• Casper RF. Basic understanding of gonadotropin-releasing hormone-agonist triggering. Fertil Steril 2015;103:867–9.
   PubMed Web of Science ®Google Scholar
• Youssef MA, Van der Veen F, Al-Inany HG, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev 2014;10:CD00804.
   Google Scholar
• Yding Andersen C, Vilbour Andersen K. Improving the luteal phase after ovarian stimulation: reviewing new options. Reprod Biomed Online 2014;28:552–9.
   PubMed Web of Science ®Google Scholar
• Engmann L, Benediva C. Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support. Fertil Steril 2012;97:531–3.
   PubMed Web of Science ®Google Scholar
• Casper RF. Introduction: gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization. Fertil Steril 2015;103:865–6.
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril 2015;103:870–3.
   PubMed Web of Science ®Google Scholar
• Kol S, Humaidan P, Alsbjerg B, et al. The updated cochrane review 2014 on GnRH agonist trigger: repeating the same errors. Reprod Biomed Online 2015;30:563–5.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Engmann L, Benadiva C. Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril 2015;103:879–85.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril 2008;90:231–3.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Comparison of “dose human chorionic gonadotropin” using leuprolide acetate alone or in combination with low-dose human chorionic. Fertil Steril 2011;95:2715–17.
   PubMed Web of Science ®Google Scholar
• Griffin D, Benadiva C, Kummer N, et al. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril 2012;97:1316–20.
   PubMed Web of Science ®Google Scholar
• Schachter M, Friedler S, Ron-El R, et al. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil Steril 2008;90:1087–93.
   PubMed Web of Science ®Google Scholar
• Lin MH, Wu FS, Lee RK, et al. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril 2013;100:1296–3.
   PubMed Web of Science ®Google Scholar
• Decleer W, Osmanagaoglu K, Seynhave B, et al. Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial. Facts Views Vis Obgyn 2014;6:203–9.
   PubMedGoogle Scholar
• Griffin D, Feinn R, Engmann L, et al. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril 2014;102:405–9.
   PubMed Web of Science ®Google Scholar
• Beck-Fruchter R, Weiss A, Lavee M, et al. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod 2012;27:1357–67.
   PubMed Web of Science ®Google Scholar
• Haas J, Zilberberg E, Dar S, et al. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles – a preliminary report. J Ovarian Res 2014;7:77–82.
   PubMed Web of Science ®Google Scholar
• Zilberberg E, Haas J, Dar S, et al. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecol Endocrinol 2015;31:145–7.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang XH, Wang WH, et al. The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet 2011;28:901–10.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006;13:173–8.
   PubMed Web of Science ®Google Scholar
• Kummer N, Benadiva C, Feinn R, et al. Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist. Fertil Steril 2011;96:63–8.
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Baruffi R, Petersen CG, et al. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol 2010;8:107–12.
   PubMed Web of Science ®Google Scholar
• Castillo JC, Moreno J, Dolz M, Bonilla-Musoles F. Successful pregnancy following dual triggering concept (rhCG + GnRH agonist) in a patient showing repetitive inmature oocytes and empty follicle syndrome: case report. J Med Cases 2013;5:221–6.
   Google Scholar